Innoveren Scientific Inc. (IVRN)

OTCMKTS · Delayed Price · Currency is USD
0.0004
-0.0003 (-42.86%)
At close: Jan 14, 2026
33.33%
Market Cap 3.20K
Revenue (ttm) n/a
Net Income (ttm) -3.26M
Shares Out 8.01M
EPS (ttm) -5.51
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 199
Average Volume 16,426
Open 0.0004
Previous Close 0.0007
Day's Range 0.0004 - 0.0004
52-Week Range 0.0000 - 0.0007
Beta 512.85
RSI 34.98
Earnings Date n/a

About Innoveren Scientific

Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Michael Yurkowsky
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol IVRN
Full Company Profile

Financial Performance

In 2022, Innoveren Scientific's revenue was $453,460, a decrease of -71.86% compared to the previous year's $1.61 million. Losses were -$10.30 million, 114.6% more than in 2021.

Financial Statements

News

There is no news available yet.